Millions would lose Medicaid coverage. Millions would be left without health insurance. Signing up for health plans on the ...

Published in the World Allergy Organization Journal, the paper gives several reasons why it's time to move on from Benadryl, ...

Real-world data found people with schizophrenia treated with injectable extended-release risperidone (Uzedy) had lower rates ...

A national study assessed changes in the proportion of adults unaware of their hypertension, diabetes, or high cholesterol ...

President Donald Trump's big bill making its way through Congress will cut taxes by $3.75 trillion but also increase deficits ...

Adding simvastatin to escitalopram did not improve depressive symptoms in patients with major depression and obesity. Add-on ...

Finally, sources told WSJ that Witty didn't have a background in the U.S. insurance industry; he was formerly the CEO of ...

The FDA approved darolutamide (Nubeqa) for metastatic castration-sensitive prostate cancer (mCSPC). The agency previously ...

CHICAGO -- A single infusion of the chimeric antigen receptor (CAR) T-cell therapy ciltacabtagene autoleucel (cilta-cel; ...

CHICAGO -- The bispecific T-cell engager tarlatamab (Imdelltra) significantly prolonged survival in the second-line treatment ...

As we brace for hotter summers and more erratic weather patterns nationwide, we must see this pollen surge not as an isolated ...

Among patients who received four-drug consolidation therapy, 84% had measurable residual disease (MRD)-negative status before ...